XML 60 R49.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Entity Wide Disclosures - Summary of Revenue by Major Source (Details) $ in Thousands | 3 Months Ended
--- | ---
Mar. 31, 2018 USD ($)
Disaggregation Of Revenue [Line Items] |
Total Revenue | $ 163,077
Oncology |
Disaggregation Of Revenue [Line Items] |
Total Revenue | 43,853
Metabolic |
Disaggregation Of Revenue [Line Items] |
Total Revenue | 22,055
Cardiology |
Disaggregation Of Revenue [Line Items] |
Total Revenue | 23,736
AVAI |
Disaggregation Of Revenue [Line Items] |
Total Revenue | 16,679
Endocrine |
Disaggregation Of Revenue [Line Items] |
Total Revenue | 6,458
Central Nervous System |
Disaggregation Of Revenue [Line Items] |
Total Revenue | 13,165
Medical Devices |
Disaggregation Of Revenue [Line Items] |
Total Revenue | 2,914
Other |
Disaggregation Of Revenue [Line Items] |
Total Revenue | $ 34,217

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 32 -Paragraph 2A -URI http://asc.fasb.org/extlink&oid=82859839&loc=SL82860478-203043 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=82913847&loc=SL49130543-203045 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=82913847&loc=SL49130539-203045 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=82913847&loc=SL49130545-203045 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_ProductOrServiceAxis=medp_OncologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=medp_MetabolicMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=medp_CardiologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=medp_AntiviralAndAntiInfectiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=medp_EndocrineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=medp_CentralNervousSystemMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=medp_MedicalDevicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=medp_OtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |